EDIC Antiplatelets

EDIC – Antiplatelets

Type A. Ticagrelor is a drug used in acute coronary syndrome due to: a) Direct inhibitor of thrombin. b) Inhibits the glycoprotein IIaIIIb. c) It is a selective inhibitor of Xa factor. d) Loading dose is 60 mg followed by 10 mg/day. e) Antiplatelet drug inhibitor of P2Y12....

Levosimendan

a) Decrease the rate of cyclic adenosine monophosphate (AMP) degradation. b) Increase in cyclic AMP concentration leading to enhanced calcium influx into the cell. c) Systemic arterial and venous dilation via inhibition of vascular phosphodiesterase. d) Increase the sensitivity of the myocardial contractile apparatus to calcium. e) Decrease in myofilament tension development and myocardial compliance....

Scroll to top